Fatal pulmonary toxicity due to carfilzomib (Kyprolis™). [electronic resource]
Producer: 20170424Description: 720-4 p. digitalISSN:- 1477-092X
- Antineoplastic Agents -- therapeutic use
- Fatal Outcome
- Humans
- Lung -- drug effects
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Neoplasm Recurrence, Local -- drug therapy
- Oligopeptides -- therapeutic use
- Proteasome Inhibitors -- therapeutic use
- Respiratory Distress Syndrome -- chemically induced
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.